[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-AZN":3,"homepage-market-summary":34,"stock-news-AZN":176},{"ticker":4,"date":5,"profile":6,"dividend":14,"quote":18},"AZN","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":9,"founded":9,"is_fund":13,"issuer":9,"category":9},"AstraZeneca PLC","NYSE",null,"Common Stock","A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.","96,100",false,{"dividend_yield":15,"annual_dividend":16,"frequency":17,"next_ex_date":9},1.0134,1.59,"Semi-Annual",{"close":19,"open":20,"high":21,"low":22,"prev_close":23,"change":24,"percent_change":25,"volume":26,"transactions":27,"vwap":28,"high_52w":29,"low_52w":30,"avg_volume_52w":31,"range_52w_percent":32,"record_count":33},156.9,158.46,158.795,156.41,157.7,-0.8,-0.51,2639437.445726,57806,157.1166,212.71001,153.4134,2743729.152163932,5.9,4436,{"status":35,"indices":36,"watchlist":80,"sectors":102,"benchmarks":158},"success",[37,45,52,59,66,73],{"symbol":38,"name":39,"price":40,"change":41,"pct_change":42,"is_up":43,"sparkline":44,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":46,"name":47,"price":48,"change":49,"pct_change":50,"is_up":43,"sparkline":51,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":53,"name":54,"price":55,"change":56,"pct_change":57,"is_up":43,"sparkline":58,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":60,"name":61,"price":62,"change":63,"pct_change":64,"is_up":43,"sparkline":65,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":67,"name":68,"price":69,"change":70,"pct_change":71,"is_up":43,"sparkline":72,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":74,"name":75,"price":76,"change":77,"pct_change":78,"is_up":13,"sparkline":79,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[81,88,95],{"symbol":82,"name":83,"price":84,"change":85,"pct_change":86,"is_up":43,"sparkline":87,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":89,"name":90,"price":91,"change":92,"pct_change":93,"is_up":43,"sparkline":94,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":96,"name":97,"price":98,"change":99,"pct_change":100,"is_up":43,"sparkline":101,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[103,108,113,118,123,128,133,138,143,148,153],{"name":104,"etf":105,"change":106,"price":107,"is_up":43},"Technology","XLK",1.01,199.81,{"name":109,"etf":110,"change":111,"price":112,"is_up":43},"Financials","XLF",0.06,53.49,{"name":114,"etf":115,"change":116,"price":117,"is_up":13},"Healthcare","XLV",-0.01,166.18,{"name":119,"etf":120,"change":121,"price":122,"is_up":43},"Consumer Cycl","XLY",1.13,110.04,{"name":124,"etf":125,"change":126,"price":127,"is_up":43},"Consumer Staples","XLP",0.25,80.53,{"name":129,"etf":130,"change":131,"price":132,"is_up":43},"Energy","XLE",0.4,62.95,{"name":134,"etf":135,"change":136,"price":137,"is_up":43},"Industrials","XLI",0.78,169.95,{"name":139,"etf":140,"change":141,"price":142,"is_up":43},"Materials","XLB",0.66,48.86,{"name":144,"etf":145,"change":146,"price":147,"is_up":43},"Real Estate","XLRE",0.32,40.81,{"name":149,"etf":150,"change":151,"price":152,"is_up":43},"Utilities","XLU",0.38,39.83,{"name":154,"etf":155,"change":156,"price":157,"is_up":43},"Comm Services","XLC",0.35,110.32,[159,164,168,172],{"ticker":160,"name":161,"price":162,"change":163,"is_up":43},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":165,"name":166,"price":167,"change":93,"is_up":43},"QQQ","Invesco QQQ Trust",749.58,{"ticker":169,"name":170,"price":171,"change":57,"is_up":43},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":173,"name":174,"price":175,"change":71,"is_up":43},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":177,"articles":178},20,[179,185,191,197,203,209,215,220,225,230,235,240,245,250,255,260,265,270,276,280],{"title":180,"link":181,"pubDate":182,"description":183,"source":184},"AstraZeneca PLC (AZN.L) Stock Price, News, Quote & History - ca.finance.yahoo.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiU0FVX3lxTFBKWm9XdEE4VWdyaVZUdW0xOWlWc0g0V3Q1eE53d1E1THZ4RGRNNDJMM1V4WVl6anN6RWhXUUdlcXFEQ29kQTE4bG9XdG9RNlNXcnk0?oc=5","Thu, 01 Oct 2026 07:55:01 GMT","AstraZeneca PLC (AZN.L) Stock Price, News, Quote & History ca.finance.yahoo.com","ca.finance.yahoo.com",{"title":186,"link":187,"pubDate":188,"description":189,"source":190},"AstraZeneca and two partners plan to test a cancer-drug pairing in breast cancer - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisAFBVV95cUxPb2IxT3BTdjQwNHZkSE5rLWhNdGVYMUN3WXp3cG13YTkzZlRSYlI2SHJPeE5na3duWWVkb0JRREhidUdPNmZsb3Q4N3F1V2lQdHRxcnl2aUpUekFsWHBETGtuU1Z5RENJUUdfOGJqSUhfeG8zSU9XYkdZMjhFb2hJVm5qc3lqaVhSRTNieVJ2Zy1EMHRwOTd2cVJBTC0wNXFGdE00TEFtM1pLM3Rob0dFdA?oc=5","Fri, 02 Oct 2026 07:22:54 GMT","AstraZeneca and two partners plan to test a cancer-drug pairing in breast cancer Stock Titan","Stock Titan",{"title":192,"link":193,"pubDate":194,"description":195,"source":196},"AstraZeneca PLC (AZN) Stock Down 1.2% -- Now Undervalued? GF Sco - gurufocus.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipgFBVV95cUxOdWg2QjhIaWdNcTBtMHJ2VUN1WlJYazhBRE5WSHZ0RHRYTmh5dDljOTRIS1pDeWpIR1NmUHByZjFGQTRrcmZtWmxqVFE1UDdXNHl0YWw4ZmJuYUdFSnI4bGFDdmczeXVoQTBmM09SRmNYbGhEcHJFcW1VVFZLTm16TzFUdjYtZmVpVEtHenZmMlBmZXU4b2RtemRhT0I3NlZkbjhub3dn?oc=5","Wed, 30 Sep 2026 00:31:59 GMT","AstraZeneca PLC (AZN) Stock Down 1.2% -- Now Undervalued? GF Sco gurufocus.com","gurufocus.com",{"title":198,"link":199,"pubDate":200,"description":201,"source":202},"Analysts back AstraZeneca's $2B Summit Therapeutics investment as stock gains (AZN:NYSE) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiswFBVV95cUxNRTdZY1JMNUlQTFNqbUhOWXFTUXZEOVVSbzA4bmdFcUd0XzNGZ0otZGh0SnlDUFFDc3RnbzRweDFhTDNneWdKTllaaGdUVm92emF2eXp0cDJ6dENYVVk5eVROVmhob01rZ2oydktUWmpqVHJxazM5UFBTamIwS094NlZ3Y2VUZDh4N0lVTm8xVUVKcmFrbW4tdTA0VEVtMjRLX1lXNlZHT3E0VGdvQUVibC1WRQ?oc=5","Tue, 29 Sep 2026 08:19:07 GMT","Analysts back AstraZeneca's $2B Summit Therapeutics investment as stock gains (AZN:NYSE) Seeking Alpha","Seeking Alpha",{"title":204,"link":205,"pubDate":206,"description":207,"source":208},"AstraZeneca (LSE:AZN) Stock May Be 48% Undervalued On Enhertu Trial Progress - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimgFBVV95cUxQT0V4ME9nSVYyNzdqTmhtYnRRUzdqY0YyekpiT19JLW05U0lNYVFMcUZSWlNGT1Q1eEJCZ3d5UmtqdkdGaEFobXY3Sm56cGpzX2R2dGhEUkc1R3lLemdRNl9fZU1QZjJMc0RibDBLVFQ5alBwWFFDcE9WRVBLU3plbzZKVWJqblZ0NkR6SlFicHljTmlWUFRUODR3?oc=5","Tue, 22 Sep 2026 07:00:00 GMT","AstraZeneca (LSE:AZN) Stock May Be 48% Undervalued On Enhertu Trial Progress Yahoo Finance","Yahoo Finance",{"title":210,"link":211,"pubDate":212,"description":213,"source":214},"A $2 Billion Reason Why AstraZeneca Stock Is Down Today - barchart.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinwFBVV95cUxNcWpkUWF2alFtU1FudjIwNWtXVVBoOGlYNDBhU0xZcS1EeVE0em9mWUJSeEEwX3I2OTdzR3FQbEJZOHk3V1JXaVIyUnlRUU9xeXVLdmtnWjcwaVBIY2puNUQ2ZHhSaXpiNjFFektmQzdublBxZDlUUjVoN29xZWt5eFNCOVZJZkZXOHNiLXFHaENSb1AxUUREZENvWXgzd3M?oc=5","Tue, 29 Sep 2026 19:39:47 GMT","A $2 Billion Reason Why AstraZeneca Stock Is Down Today barchart.com","barchart.com",{"title":216,"link":217,"pubDate":218,"description":219,"source":190},"Employee schemes bring 9,828 new AstraZeneca (AZN) shares to London Stock Exchange trading. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirwFBVV95cUxQRVM5RUlBV3RpbXRVbEFaV3ZwNi03TWZPUE1oQk9vcG9xUThzN0FhMkg2a0k2RVNGT3R6ZDloZ013RUljVEM3bGQyTnQ3b0d1alVWS2M3MTZtbkY0UmdsT3NkNWwxcldabEhDOGxSZS1WNW14MHVBR0UxUFR6NE96bC1qMXZZblNhN0VHbU9LYnNRY3V5U25uRDJDR2ZHUzVRYndnanlJRlF0YUdQZWJn?oc=5","Thu, 01 Oct 2026 15:41:16 GMT","Employee schemes bring 9,828 new AstraZeneca (AZN) shares to London Stock Exchange trading. Stock Titan",{"title":221,"link":222,"pubDate":223,"description":224,"source":202},"Why AstraZeneca Still Looks Underrated Despite Strong EPS Momentum (NYSE:AZN) - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqwFBVV95cUxPQkkxa1FGeEQ2ZnZNY3gzOUtWX3Q2MXRrQzd0dy1kVkVxUTd5c3VHSWlmM210LTNIdlJaU2Zpa1Z3LU5jZ3lGUlBYWl9GQll1bDdUQVQyeW1zZGFVQ3VQRndmaTIyZEVRd0RxbFZ3dUROMThDdFFKY2RLdFFrcnVWMUVvZ2JGVE9xaFNsQUdOOGZ6Q0dzRTVRMzJJV2plMFZOZzhkalFmQlpOZkE?oc=5","Fri, 25 Sep 2026 13:15:45 GMT","Why AstraZeneca Still Looks Underrated Despite Strong EPS Momentum (NYSE:AZN) Seeking Alpha",{"title":226,"link":227,"pubDate":228,"description":229,"source":208},"Astrazeneca (AZN) Ascends But Remains Behind Market: Some Facts to Note - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipgFBVV95cUxNbUhfVkxRU1B0SGNYX2xUV0trRXU3SmVNdWFQLU1SOS00SE5oNEdQTFRFTnZOMWZ5UEpHSWJiYlFmYWk3eU9CUDV2anVhVWNDdTBJZTlVWFRZcUk5TDluVURnc1I4SXhOMGdhQ0hvQmZIc1R6UVNTQy0yejZOU0VpS1JxQnUtSEltRUREZnZIeWZCdi1MRHpOSXNTeV8tZWhNMjU5c21R?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","Astrazeneca (AZN) Ascends But Remains Behind Market: Some Facts to Note Yahoo Finance",{"title":231,"link":232,"pubDate":233,"description":234,"source":190},"AstraZeneca and Summit plan to study two cancer treatments together in digestive cancers. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxQOUdFV3pHM0N3MXpMYkRjaE0ySWp0NHBQa2RlYkZPN3BnbFJZWU1iRENGV3ZZNTF2RDVZWGd6NHoxR2tqVVZjaVVtU0JBN1lSbThueFdtVGhHYk4tUWlEMjcwZFE5R0ktWkE2eHNQaGtxSkc5RWEwbFAtSzhOaDE3a1lCdGVkU0pYMjhscFdCTWcyNGZuUHZ5NzNxTkZJNVNBMVdVZ2pTcXozcjl1VGNydkZTWG54YnNxOVRqOQ?oc=5","Mon, 28 Sep 2026 21:30:00 GMT","AstraZeneca and Summit plan to study two cancer treatments together in digestive cancers. Stock Titan",{"title":236,"link":237,"pubDate":238,"description":239,"source":202},"AstraZeneca granted EU label expansion for COPD therapy, Trixeo in asthma - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilAFBVV95cUxQTnhSSEpUZnFmQXNfaUJSYldGNHBEbjlGMF9sQTVFVmF3UnRfSDh6eC1haDBLbFYxblBWQS1tYWZPb3pKTWZXUDZIV0RLQm5hWnEtdXlrQXlUQ2I0VDdmb05INTBvdy1uTFV6UGgxaGZCRkpVb2dPS1huamhQZ0RmZFlfMGNiVTNjUTB1MlFUT21KNnE5?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","AstraZeneca granted EU label expansion for COPD therapy, Trixeo in asthma Seeking Alpha",{"title":241,"link":242,"pubDate":243,"description":244,"source":208},"AstraZeneca (AZN): Can Precision Medicine Offset a Narrower Breast Cancer Market? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxQOVhEemU3UUNyOW5Jbi0wRTZrVVFNUzBKR3Z2WGFVQ2R4UHVMM2pUblFxVnhuaDRFc1JRRTJ1Y3lyOEJCV1dLWVVIaVBvUmhfcE5TREFTS2Z0UHVMZVR0a3hrSDNXV25BUmNGc3NOQ1AwdlVZOU1pYTlYd3BheTF4c0NGWWhYYkJYcmd2eEo1cWtxaUpvMzRLbDVFYVgxLXBXRTh2dQ?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","AstraZeneca (AZN): Can Precision Medicine Offset a Narrower Breast Cancer Market? Yahoo Finance",{"title":246,"link":247,"pubDate":248,"description":249,"source":190},"With no treasury shares, AstraZeneca (AZN) reports 1.55B voting rights. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirwFBVV95cUxONFRNdmZZanVWMElVRnNpeVhKbHFDOHVMVDBoN09Tb1h5ZFlmWm9ydUdNSk9jRXpMMGJNaG1jaGJ1QU1tTFd1MFBJQm9MZm8yaXREMUkyU3hPbjZtNXpmV19pVlFkX2dLYVVpeVl3emRDY3BTcEVUM3RleEVsQXpxekliYzNESExYUy1OYzRTZXJzWHgzZWtuZ3RSSkZXOUdpcGNqcnp2Q2JlemU0M19N?oc=5","Thu, 01 Oct 2026 15:32:30 GMT","With no treasury shares, AstraZeneca (AZN) reports 1.55B voting rights. Stock Titan",{"title":251,"link":252,"pubDate":253,"description":254,"source":208},"Is AstraZeneca (LSE:AZN) Undervalued Following Its New Lung Cancer FDA Filing? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxNak8xNkJ0bVNFWmt0RXNsRV9nR1VvUE9Bd3VNUWM1d1FoWThFSmtWb09KYkxZaEk3RmRXemNIczR2eGh1MzR2Zk5yaTh5NnVzYlp5a2ltLUtWY2txeXFJR3pIVFctY3NJN2N6VDFXUERybFktLUlQZTBXRW4zZjloQ2RKTDdfZTNuaVZEenROSHNXT2RyamVkems4RW8yM05kcGZaTA?oc=5","Wed, 30 Sep 2026 10:09:53 GMT","Is AstraZeneca (LSE:AZN) Undervalued Following Its New Lung Cancer FDA Filing? Yahoo Finance",{"title":256,"link":257,"pubDate":258,"description":259,"source":190},"Rights equivalent to a 12% stake await closing as AstraZeneca (AZN) agrees to invest in Summit. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirwFBVV95cUxNTkhzRG9KbGhTRGxtMWd1TUZCdFZlRVlpd0k3T1pKcFh6NkZFVWU4MExFSnJoakdrSGRvWlYzSG5RclQ4R0RTTDliUllRc1NUWFl3cXZzYTVsTmJmSkNSdjNfeGlDRWRtbmttdnlKbl9hTmtQZmdxMFlXbVZRbFg5c0NzNXRuWGt6ajlrMUFVQi1qY2F2WlVja1V4dHNmQzlNOXd3SF96UDVhdUk2aWdJ?oc=5","Tue, 29 Sep 2026 10:41:37 GMT","Rights equivalent to a 12% stake await closing as AstraZeneca (AZN) agrees to invest in Summit. Stock Titan",{"title":261,"link":262,"pubDate":263,"description":264,"source":208},"Astellas Pharma (TSE:4503) Stock Could Be 39% Below Fair Value On Cash Flow - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxOV2R0MUx0Z2g2cFFYcEZ5WWFYUjg0dmpBOWdmQ3RWbFd3dHpOaDlEZ0xlaF9handMQ29nZzZMbGp0ZWxFUU9ETV9iR0RLMXlLcEhqcVdiWGVaekdFNW1nb0lPbG5Wakw4bS1GWnZNOVFQdE5pMDl0RFFBV3ZlQUdjZGVTNU14MVBJOHFiV0o5ZmJjRHlmNUtqdmtFZw?oc=5","Sat, 26 Sep 2026 18:09:11 GMT","Astellas Pharma (TSE:4503) Stock Could Be 39% Below Fair Value On Cash Flow Yahoo Finance",{"title":266,"link":267,"pubDate":268,"description":269,"source":190},"Lung and breast cancers are targets of AstraZeneca (AZN)'s new three-company trial collaboration. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirwFBVV95cUxOd3VsNzJMRG9rOFppRGpERERHSkZlNEQtby1HaXByOFJ3LXNSam1LNzlEZ1FKYzkwUVVCQldqNFhZNWxLdG9Yd2paZFZiNjdiaFlGRVFCUXZTb2pVUHd2NThfeVlyVHk1VnotQTNPREE4NEJ1LXNTc1ZsYWlwQmFzdzVCbThHblJjNXBYcHB2cDBtRlVNQ3dackt4OGRlQkMxcTlGdHJnMlJTNWdBTUdV?oc=5","Fri, 02 Oct 2026 10:59:08 GMT","Lung and breast cancers are targets of AstraZeneca (AZN)'s new three-company trial collaboration. Stock Titan",{"title":271,"link":272,"pubDate":273,"description":274,"source":275},"Astrazeneca (AZN) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance Singapore","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijwFBVV95cUxPdzN3REVRdzhOTmZPM3FQTFFFLURVY1NVV1k5YXRRZjRpS294cm1EMHdlbzlxXzZOWC1yWkpJVjBZSHhJQlBZTFZSU2dYWnBsYUNVejlYN0FQRXRnQ19hdWNOYk11aUdQN3dWOHF1NWs3SDYyc0lSbjduMjkzSVVIdXJJczhra3Bib3g5cm9LTQ?oc=5","Tue, 29 Sep 2026 21:15:05 GMT","Astrazeneca (AZN) Registers a Bigger Fall Than the Market: Important Facts to Note Yahoo Finance Singapore","Yahoo Finance Singapore",{"title":277,"link":278,"pubDate":228,"description":279,"source":208},"AZN vs. MRK: Comparing Keytruda, Pipelines and Growth Strategies - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilAFBVV95cUxOZE5uY3JoNWRJRy1zZGdsMkx4RGU5Q2J4RzZXUVlweDdPOWloM0Z1T0RuSS1qLTctMnhXWTlhaFlkZy1aMkllMkhNMmZkLWo5SEFDaDBWS3ltaEhaSlp4MHMyY0NnNGEzWXBYeE5naTBwUGpfQ1hFaXRveE1CY0puY2lTd1JGZnNxLW84dmpQdHd0QzVs?oc=5","AZN vs. MRK: Comparing Keytruda, Pipelines and Growth Strategies Yahoo Finance",{"title":281,"link":282,"pubDate":283,"description":284,"source":208},"Is AstraZeneca's Oncology Portfolio Positioned for Continued Growth? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiswFBVV95cUxOQ2U1QnBPYWEwZGJlMXdvaVBsWmQ5OWJNX1U2MlBZd3Nyb2xMdndpdWVOZ0xCX3FuYUpBbmc5bDE3RHlZY1RrVjhJS1F1enRtQ1UtRlZxR1kySzFIYndISElHZlFkLXZUNkRVZUstRnQ5aEptUXpPanlIYVd4R21PcHl3VG5hdHdGczJuNVYxa1gxRVo5T2otbUZJTDZXRW00Q05yUjJ0UlBHYy1EMGZMOEdGSQ?oc=5","Mon, 28 Sep 2026 13:02:00 GMT","Is AstraZeneca's Oncology Portfolio Positioned for Continued Growth? Yahoo Finance"]